language

Home

Cytarabine for Injection

Description: White to off-white lyophilized lumps

Category:

Antineoplastics / Oncology

Email:

thomasyan9733@vip.163.com

Pharmaceuticals:

+86-15230180709

Medical Devices:

+86-18603110901

Request a Quote

Description

产品描述

Product Information
Product Name: Cytarabine for Injection
Specification: 0.5g
Active Ingredient: Cytarabine
Description: White to off-white lyophilized lumps
Indications:
Acute Leukemia:
Acute Myeloid Leukemia (AML): Used as a core drug for induction remission and consolidation therapy.
Acute Lymphoblastic Leukemia (ALL): Frequently combined with other chemotherapeutic agents.
Other Malignancies: May be administered to some patients with high-risk Myelodysplastic Syndrome (MDS) or lymphoma.

FAQs

What main products does Baotai Pharmaceutical supply?

We provide human finished medicines, veterinary drugs, medical devices & consumables, pharmaceutical production equipment and professional technology transfer services.

Which countries and regions do you mainly export to?

Our business covers Southeast Asia, CIS countries, Africa, Middle East and Latin America, including Philippines, Uzbekistan, Vietnam, Ethiopia and more.

Does your company have international GMP qualification support?

Our team is proficient in EU-GMP and PICS regulations. We hold multiple overseas product registrations and assist factories in passing international GMP audits.

Can you help complete local drug registration in target countries?

Yes. We offer full-set overseas product registration application and approval consulting services for global clients.

What therapeutic areas do your human medicines focus on?

Our medicines mainly cover cardiovascular, antiviral, anti-tumor and other high-standard treatment fields.

Do you cooperate with formal domestic pharmaceutical manufacturers?

We maintain long-term stable partnerships with top Chinese pharmaceutical groups to guarantee product quality and supply stability.